INTERVIEW

Chugai to Execute Area-Based Strategy Centering on General Reps: Marketing Chief

March 6, 2017
Chugai Pharmaceutical will implement organizational reform centering around its marketing structure on April 1. It will divide its 11 current branch offices into 36 branch offices that will largely focus on business within a single prefecture, and it will establish…

To read the full story

INTERVIEW

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…